Environmental Oxygen Transitions and Aspergillosis Disease Progression
环境氧转变和曲霉病进展
基本信息
- 批准号:10404535
- 负责人:
- 金额:$ 52.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:Acute leukemiaAdrenal Cortex HormonesAlanine TransaminaseAntifungal AgentsAntifungal TherapyAspergillosisAspergillus fumigatusAutoimmunityChronicCollectionDataDefectDevelopmentDiseaseDisease OutcomeDisease ProgressionDoseEnvironmentExhibitsFungal GenesGenesGeneticGenetic ScreeningGenetic TranscriptionGrowthHealthHomeostasisHumanHypoxiaImmuneInfectionIntegration Host FactorsKnowledgeLeadLungMetabolicMetabolismMicrobial BiofilmsModelingMoldsMolecularMorbidity - disease rateMycosesNamesNatural ImmunityOxygenPathway interactionsPatientsPhenotypeProductionRegulationResearchRoleSiteTestingTissuesTransplant RecipientsVirulenceWorkbasechemotherapyfitnessflexibilityfungusgenetic effectorgraft vs host diseasehematopoietic cell transplantationimprovedin vivoin vivo imaginginnovationinsightmetabolomemortalitymutantnovelnovel therapeuticspathogenic funguspatient populationresponsetherapeutic targettranscription factortranscriptome
项目摘要
Project Summary.
Invasive aspergillosis (IA) is a major cause of infectious morbidity and mortality in immune compromised
patients, particularly those with acute leukemia, hematopoietic cell transplantation, and recipients of chronic
corticosteroid therapy for graft versus host disease and autoimmunity. Despite recent advances in antifungal
therapies, it remains poorly understood which fungal and host factors are critical for disease progression after
establishment of infection in the lung. We have made 2 fundamental observations toward narrowing this
knowledge gap. First, the causative agent of IA, Aspergillus fumigatus, interacts with host tissue to generate a
dynamic oxygen microenvironment at the site of infection. Second, A. fumigatus adapts to established infection
microenvironments by exhibiting infection site-specific metabolic flexibility that is critical for fungal virulence.
We recently termed these adaptations “disease progression factors” (DPFs) because they are essential for the
progression of invasive disease and relatively undefined in the context of human fungal infections. An exciting
recent discovery is the previously unappreciated role of the fungal oxygen response genetic network, which
includes the DPFs, SrbA, SrbB and CreA, in responses to transitions in oxygen tension. Our recent data lead
us to hypothesize that this oxygen response network regulates the production of specific metabolites that
promote and support fungal disease progression. A major effector of this genetic network, an unstudied fungal
alanine aminotransferase alaA, is the focus of mechanistic studies in Aim 1 of this proposal. We propose a
model whereby alaA functions as key regulator of metabolic transitions required for adaptation to oxygen
fluctuations during fungal disease progression. In aim 2, we build off a novel genetic screen which has
identified four new unstudied fungal transcription factors that are critical for the response to oxygen tension
fluctuations. We have named these new genes ortA-D for oxygen responsive fungal transcription factors. An
innovation to our approach to test our hypotheses and models is the incorporation of in vivo imaging of the
infection site microenvironment during disease progression that is revealing new insights into fungal form and
function in an established infection. Consequently, at the conclusion of these studies, we will have defined new
molecular mechanisms of fungal fitness in established infection environments that are expected to reveal new
therapeutic opportunities to improve disease outcomes for these too often lethal invasive mold infections.
项目摘要。
侵入性曲霉菌病(IA)是免疫疾病中传染性发病和死亡率的主要原因
患者,尤其是患有急性白血病,造血细胞移植的患者和慢性病患者
皮质类固醇治疗用于移植物与宿主疾病和自身免疫性。尽管最近的抗真菌进展
疗法,哪些真菌和宿主因素对于疾病进展至关重要,在
在肺部建立感染。我们已经对缩小这一点进行了2个基本观察
知识差距。首先,IA的病因,曲霉的烟曲霉与宿主组织相互作用以产生A
感染部位的动态氧微环境。第二,烟曲霉适应已建立的感染
微环境通过表现出对真菌病毒至关重要的感染特异性代谢灵活性。
我们最近称这些适应为“疾病进展因素”(DPF),因为它们对于
在人类真菌感染的背景下,侵入性疾病的进展和相对不确定。令人兴奋的
最近的发现是真菌氧反应遗传网络的先前未欣赏的作用,
包括DPF,SRBA,SRBB和CREA,对氧张力的过渡响应。我们最近的数据负责人
我们假设这种氧反应网络调节了特定代谢产物的产生
促进和支持真菌疾病进展。这个遗传网络的主要效应子,一种未研究的真菌
丙氨酸氨基转移酶ALAA是本提案目标1的机械研究重点。我们提出了一个
ALAA充当适应氧所需的代谢过渡的关键调节剂的模型
真菌疾病进展过程中的波动。在AIM 2中,我们建立了一个具有新颖的遗传屏幕
确定了四个新的未研究的真菌转录因子,这对于对氧气张力的反应至关重要
波动。我们为氧气响应真菌转录因子命名了这些新基因ORTA-D。一个
对我们测试假设和模型的方法的创新是纳入体内成像
疾病进展过程中感染部位的微环境正在揭示对真菌形式的新见解和
在已建立的感染中起作用。因此,在这些研究的结论中,我们将定义新的
在已建立的感染环境中真菌适应性的分子机制,这些环境有望揭示新的
这些经常致命的侵入性霉菌感染的治疗机会可以改善疾病结局。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Andrew Cramer其他文献
Robert Andrew Cramer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Andrew Cramer', 18)}}的其他基金
Antifungal Immunity and the Mechanism of Fungal Programmed Cell Death
抗真菌免疫和真菌程序性细胞死亡机制
- 批准号:
10538624 - 财政年份:2019
- 资助金额:
$ 52.94万 - 项目类别:
Environmental Oxygen Transitions and Aspergillosis Disease Progression
环境氧转变和曲霉病进展
- 批准号:
10615129 - 财政年份:2019
- 资助金额:
$ 52.94万 - 项目类别:
Antifungal Immunity and the Mechanism of Fungal Programmed Cell Death
抗真菌免疫和真菌程序性细胞死亡机制
- 批准号:
10320401 - 财政年份:2019
- 资助金额:
$ 52.94万 - 项目类别:
Overcoming Emerging Aspergillus fumigatus Azole Resistance Via Protease Inhibition
通过蛋白酶抑制克服新出现的烟曲霉唑抗性
- 批准号:
10547781 - 财政年份:2019
- 资助金额:
$ 52.94万 - 项目类别:
Antifungal Immunity and the Mechanism of Fungal Programmed Cell Death
抗真菌免疫和真菌程序性细胞死亡机制
- 批准号:
10079460 - 财政年份:2019
- 资助金额:
$ 52.94万 - 项目类别:
Environmental Oxygen Transitions and Aspergillosis Disease Progression
环境氧转变和曲霉病进展
- 批准号:
10161719 - 财政年份:2019
- 资助金额:
$ 52.94万 - 项目类别:
Overcoming Emerging Aspergillus fumigatus Azole Resistance Via Protease Inhibition
通过蛋白酶抑制克服新出现的烟曲霉唑抗性
- 批准号:
10334562 - 财政年份:2019
- 资助金额:
$ 52.94万 - 项目类别:
Overcoming Emerging Aspergillus fumigatus Azole Resistance Via Protease Inhibition
通过蛋白酶抑制克服新出现的烟曲霉唑抗性
- 批准号:
10320260 - 财政年份:2019
- 资助金额:
$ 52.94万 - 项目类别:
相似国自然基金
NPC1调控肾上腺皮质激素分泌影响代谢稳态的机制研究
- 批准号:82370796
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
下丘脑室旁核促肾上腺皮质激素释放激素神经元调控奖赏偏好行为的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
下丘脑室旁核促肾上腺皮质激素释放激素神经元调控奖赏偏好行为的机制研究
- 批准号:32200798
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
孕期促肾上腺皮质激素释放激素(CRH)通过引起DNA甲基化发生程序化稳定改变长期影响婴幼儿神经行为发育
- 批准号:82103851
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
INSM1在静默性促肾上腺皮质激素细胞腺瘤发生发展中的调控机制及潜在靶向治疗研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Development and Preclinical Evaluation of Nanoformulations in Liver Fibrotic Mice
肝纤维化小鼠纳米制剂的开发和临床前评价
- 批准号:
10639037 - 财政年份:2023
- 资助金额:
$ 52.94万 - 项目类别:
An innovative non-thiazolidinedione pan-PPAR agonist therapeutic for Alcoholic Hepatitis
一种创新的非噻唑烷二酮类泛 PPAR 激动剂,用于治疗酒精性肝炎
- 批准号:
10482468 - 财政年份:2022
- 资助金额:
$ 52.94万 - 项目类别:
Environmental Oxygen Transitions and Aspergillosis Disease Progression
环境氧转变和曲霉病进展
- 批准号:
10615129 - 财政年份:2019
- 资助金额:
$ 52.94万 - 项目类别:
Environmental Oxygen Transitions and Aspergillosis Disease Progression
环境氧转变和曲霉病进展
- 批准号:
10161719 - 财政年份:2019
- 资助金额:
$ 52.94万 - 项目类别:
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
稳定儿童肝移植受者的免疫抑制撤药
- 批准号:
8054698 - 财政年份:2010
- 资助金额:
$ 52.94万 - 项目类别: